Showing results (971-980 of 1,344) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|June 11, 2014
Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancyM R Luizon, A C T Palei, V C Sandrim, et al.
The Pharmacogenomics Journal|January 28, 2015
Network analysis of gene expression in peripheral blood identifies mTOR and NF-κB pathways involved in antipsychotic-induced extrapyramidal symptomsS Mas, P Gassó, E Parellada, et al.
The Pharmacogenomics Journal|March 18, 2015
Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancerE J Kap, P Seibold, S Richter, et al.
The Pharmacogenomics Journal|May 23, 2023
SLCO1B1*5 is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohortEmma F Magavern, David A van Heel, , et al.
The Pharmacogenomics Journal|August 27, 2021
Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivorsA Shalmiev, G Nadeau, M Aaron, et al.
The Pharmacogenomics Journal|September 10, 2021
Polymorphisms at CYP enzymes, NR1I2 and NR1I3 in association with virologic response to antiretroviral therapy in Brazilian HIV-positive individualsCamila de Almeida Velozo, Tailah Bernardo de Almeida, Marcelo Costa Velho Mendes de Azevedo, et al.
The Pharmacogenomics Journal|January 6, 2026
Combined Role of CYP3A4 and CYP3A5 genetic variants in tacrolimus dose-adjusted trough levels: a clinical retrospective study in kidney transplant patientsAnna Tsironi, Effrosyni Mendrinou, Stavroula Siamoglou, et al.
The Pharmacogenomics Journal|October 30, 2025
Mitochondrial DNA variants and susceptibility to anti-tuberculosis drug-induced liver injury in Korean patientsVinh Hoa Pham, Sang-Heon Kim, Young-Koo Jee, et al.
The Pharmacogenomics Journal|November 5, 2025
Genetic and pharmacokinetic factors associated with imatinib-induced toxicities in gastrointestinal stromal tumorsWei Zhuang, Yi Zeng, Xinping Lin, et al.
The Pharmacogenomics Journal|October 29, 2025
Genomic biomarkers of liver toxicity risk from UK Biobank dataAnna Shteto, Jawad Boulahfa, Adrien Etcheto, et al.
Pageof 135